We are live on ! Find out more
SRPT icon

Sarepta Therapeutics
SRPT

177 hedge funds and large institutions have $1.08B invested in Sarepta Therapeutics in 2016 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

72.29% more ownership

Funds ownership: 0% → 72.29% (+72%)

17% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 54

9% more call options, than puts

Call options by funds: $212M | Put options by funds: $195M

5% less funds holding

Funds holding: 186 → 177 (-9)

14% less first-time investments, than exits

New positions opened: 43 | Existing positions closed: 50

58% less capital invested

Capital invested by funds: $2.59B → $1.08B (-$1.51B)

64% less funds holding in top 10

Funds holding in top 10: 11 → 4 (-7)

Holders
177
Holders Change
-9
Holders Change %
-4.84%
% of All Funds
4.42%
Holding in Top 10
4
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-63.64%
% of All Funds
0.1%
New
43
Increased
63
Reduced
54
Closed
50
Calls
$212M
Puts
$195M
Net Calls
+$17.1M
Net Calls Change
+$274M

Top Buyers

1
CC
Carlson Capital
Texas
+$88.5M
2
SM
Sabby Management
Florida
+$59.4M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$27.9M
4
BFA
BlackRock Fund Advisors
California
+$21.6M
5
CCM
Cadian Capital Management
New York
+$14M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$77M
2
Millennium Management
Millennium Management
New York
-$64.8M
3
JG
Jefferies Group
New York
-$59.3M
4
RG
Redmile Group
California
-$39.3M
5
Jennison Associates
Jennison Associates
New York
-$33.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
201
BlueCrest Capital Management
Jersey
– -$506K -8,232 Closed
BFM
202
Boothbay Fund Management
New York
– -$314K -7,830 Closed
OC
203
Oppenheimer & Co
New York
– -$405K -6,602 Closed
BCM
204
Bluefin Capital Management
New York
– -$257K -6,400 Closed
Prudential Financial
205
Prudential Financial
New Jersey
– -$393K -6,390 Closed
LCG
206
Lisanti Capital Growth
New York
– -$332K -5,405 Closed
Two Sigma Advisers
207
Two Sigma Advisers
New York
– -$330K -5,366 Closed
ICM
208
IMS Capital Management
Oregon
– -$315K -5,132 Closed
Teacher Retirement System of Texas
209
Teacher Retirement System of Texas
Texas
– -$289K -4,712 Closed
AB
210
Amalgamated Bank
New York
– -$278K -4,521 Closed
SO
211
STRS Ohio
Ohio
– -$257K -4,200 Closed
CPA
212
Cowen Prime Advisors
New York
– -$246K -4,000 Closed
BRWA
213
B. Riley Wealth Advisors
Florida
– -$241K -3,910 Closed
Federated Hermes
214
Federated Hermes
Pennsylvania
– -$239K -3,887 Closed
LFR
215
Lehman Financial Resources
Pennsylvania
– -$237K -3,861 Closed
AIP
216
Ameritas Investment Partners
Nebraska
– -$227K -3,690 Closed
QSS
217
Quantitative Systematic Strategies
Florida
– -$202K -3,312 Closed
JT
218
Jump Trading
Illinois
– -$113K -1,833 Closed
Asset Management One
219
Asset Management One
Japan
– -$90K -1,490 Closed
FMA
220
FNY Managed Accounts
New York
– -$49.1K -800 Closed
AA
221
Apriem Advisors
California
– -$31K -500 Closed
AIM
222
Anchor Investment Management
South Carolina
– -$24.6K -400 Closed
JCM
223
Jacobi Capital Management
Pennsylvania
– -$18K -300 Closed
CHP
224
Cable Hill Partners
Oregon
– -$7K -111 Closed
IWMPD
225
Integrated Wealth Management (Palm Desert)
California
– -$1K -10 Closed
6 7 8
9
10

SRPT Hedge Fund Activity: Q4 2016 in Review

177 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Sarepta Therapeutics (SRPT) for Q4 2016, worth a combined $1.08B — down 58% from $2.59B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of SRPT and 43 opened new positions — a net loss of 7 holders — while 54 trimmed existing stakes and 63 added.

The largest buyer was Carlson Capital, opening a new position worth an estimated $88.5M. The largest seller was Point72 Asset Management, cutting an estimated $77M.

  • 177 institutional investors held Sarepta Therapeutics (SRPT) as of Q4 2016, down from 186 in Q3 2016.
  • Funds reported $1.08B of Sarepta Therapeutics stock for Q4 2016, down 58% quarter-over-quarter.
  • 43 funds opened new Sarepta Therapeutics positions in Q4 2016 and 50 closed out, a net change of -7 holders.
  • The largest Sarepta Therapeutics buyer in Q4 2016 was Carlson Capital, an estimated $88.5M added.
  • The largest Sarepta Therapeutics seller in Q4 2016 was Point72 Asset Management, an estimated $77M sold.

Based on aggregated 13F filings for Q4 2016.